Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis
Acta Haematologica Polonica · 29.10.2026 · 57 (5) · 371-379
DOI: 10.5603/ahp.113063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Haematologica Polonica, online erschienen am 29.10.2026. Verfasst von Jagoda Tryc-Szponder und 3 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tryc-Szponder, J., Więckowska, B., Tresckow, B. V., & Gil, L. (2026). Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis. Acta Haematologica Polonica, 57(5), 371-379. https://doi.org/10.5603/ahp.113063
Vancouver
Tryc-Szponder J, Więckowska B, Tresckow BV, Gil L. Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis. Acta Haematologica Polonica. 2026;57(5):371-379. doi:10.5603/ahp.113063
BibTeX
@article{TrycSzponder2026,
author = {Tryc-Szponder, Jagoda and Więckowska, Barbara and Tresckow, Bastian Von and Gil, Lidia},
title = {Allogeneic stem cell transplantation remains an effective therapeutic option for patients with relapsed/refractory Hodgkin lymphoma: a Polish single-center retrospective analysis},
journal = {Acta Haematologica Polonica},
year = {2026},
volume = {57},
number = {5},
pages = {371--379},
doi = {10.5603/ahp.113063}
}
EUVIMED